Sea Global Medical Instruments Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 25-07-2024
- Paid Up Capital ₹ 1.00 M
as on 25-07-2024
- Company Age 8 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 16.84 M
as on 25-07-2024
- Revenue 1.81%
(FY 2023)
- Profit 51.64%
(FY 2023)
- Ebitda 80.51%
(FY 2023)
- Net Worth 56.24%
(FY 2023)
- Total Assets 29.37%
(FY 2023)
About Sea Global Medical Instruments
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.68 Cr.
Kasturi Gupta, Shubham Gupta, and Sumeet Gupta serve as directors at the Company.
- CIN/LLPIN
U51909WB2016PLC217348
- Company No.
217348
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
30 Aug 2016
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Haripur, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sea Global Medical Instruments?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kasturi Gupta  | Additional Director | 28-Dec-2018 | Current |
| Shubham Gupta | Director | 31-Mar-2022 | Current |
| Sumeet Gupta | Additional Director | 30-Jan-2023 | Current |
Financial Performance and Corporate Structure Insights of Sea Global Medical Instruments.
Sea Global Medical Instruments Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.81% increase. The company also saw a substantial improvement in profitability, with a 51.64% increase in profit. The company's net worth Soared by an impressive increase of 56.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sea Global Medical Instruments?
In 2023, Sea Global Medical Instruments had a promoter holding of 39.40% and a public holding of 60.60%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
21 years 9 months Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Nov 2023 | ₹1.10 Cr | Open |
Others Creation Date: 18 Nov 2023 | ₹5.84 M | Open |
How Many Employees Work at Sea Global Medical Instruments?
Sea Global Medical Instruments has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sea Global Medical Instruments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sea Global Medical Instruments's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
